title: The evolutionary rate of antibacterial drug targets.
abstract: BACKGROUND
  One of the major issues in the fight against infectious diseases is the notable increase in multiple drug resistance in pathogenic species. For that reason, newly acquired high-throughput data on virulent microbial agents attract the attention of many researchers seeking potential new drug targets. Many approaches have been used to evaluate proteins from infectious pathogens, including, but not limited to, similarity analysis, reverse docking, statistical 3D structure analysis, machine learning, topological properties of interaction networks or a combination of the aforementioned methods. From a biological perspective, most essential proteins (knockout lethal for bacteria) or highly conserved proteins (broad spectrum activity) are potential drug targets. Ribosomal proteins comprise such an example. Many of them are well-known drug targets in bacteria. It is intuitive that we should learn from nature how to design good drugs. Firstly, known antibiotics are mainly originating from natural products of microorganisms targeting other microorganisms. Secondly, paleontological data suggests that antibiotics have been used by microorganisms for million years. Thus, we have hypothesized that good drug targets are evolutionary constrained and are subject of evolutionary selection. This means that mutations in such proteins are deleterious and removed by selection, which makes them less susceptible to random development of resistance. Analysis of the speed of evolution seems to be good approach to test this hypothesis.
  
  
  RESULTS
  In this study we show that pN/pS ratio of genes coding for known drug targets is significantly lower than the genome average and also lower than that for essential genes identified by experimental methods. Similar results are observed in the case of dN/dS analysis. Both analyzes suggest that drug targets tend to evolve slowly and that the rate of evolution is a better predictor of drugability than essentiality.
  
  
  CONCLUSIONS
  Evolutionary rate can be used to score and find potential drug targets. The results presented here may become a useful addition to a repertoire of drug target prediction methods. As a proof of concept, we analyzed GO enrichment among the slowest evolving genes. These may become the starting point in the search for antibiotics with a novel mechanism.
authors: Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Pawinskiego 5A, Warsaw, Poland.
authors: Arkadiusz
authors: A
authors: Gladki
authors: Szymon
authors: S
authors: Kaczanowski
authors: Pawel
authors: P
authors: Szczesny
authors: Piotr
authors: P
authors: Zielenkiewicz
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001419:Bacteria / Q000187:drug effects / Q000235:genetics; D001426:Bacterial Proteins / Q000187:drug effects / Q000235:genetics*; D004755:Enterobacteriaceae / Q000187:drug effects / Q000235:genetics; D019143:Evolution, Molecular; D020043:Genes, Essential
chemical_list: D000900:Anti-Bacterial Agents; D001426:Bacterial Proteins
references: Pharmacol Ther. 2002 Jul;95(1):1-20
references: 12163125
references: PLoS One. 2008;3(11):e3685
references: 18997863
references: Sci China C Life Sci. 2009 Apr;52(4):398-404
references: 19381466
references: J Mol Biol. 1996 Mar 29;257(2):342-58
references: 8609628
references: Science. 2012 Aug 31;337(6098):1107-11
references: 22936781
references: Trends Microbiol. 2009 Oct;17(10):433-8
references: 19765999
references: Nucleic Acids Res. 2006 Jul 1;34(Web Server issue):W219-24
references: 16844997
references: Nucleic Acids Res. 2011 Jan;39(Database issue):D1035-41
references: 21059682
references: Trends Ecol Evol. 2000 Dec 1;15(12):496-503
references: 11114436
references: Genome Res. 2002 Jun;12(6):962-8
references: 12045149
references: J Antimicrob Chemother. 2011 Sep;66(9):1941-4
references: 21700626
references: Nat Rev Drug Discov. 2003 Aug;2(8):613-23
references: 12904811
references: Nucleic Acids Res. 2009 Jan;37(Database issue):D455-8
references: 18974178
references: Nat Rev Microbiol. 2005 Nov;3(11):870-81
references: 16261170
references: Nat Genet. 2000 May;25(1):25-9
references: 10802651
references: Eur Respir J Suppl. 2002 Jul;36:78s-86s
references: 12168750
references: Nucleic Acids Res. 2010 Jan;38(Database issue):D355-60
references: 19880382
references: Nucleic Acids Res. 2009 Jan;37(Database issue):D539-43
references: 18957442
references: J Med Chem. 1974 Jan;17(1):23-8
references: 4357096
references: Nucleic Acids Res. 2009 Jan;37(Database issue):D448-54
references: 18845571
references: J Theor Biol. 2010 Jan 21;262(2):284-94
references: 19833135
references: Nature. 2011 Aug 31;477(7365):457-61
references: 21881561
references: Pharmacol Rev. 2005 Mar;57(1):117-45
references: 15734729
references: PLoS One. 2009 Jul 10;4(7):e6195
references: 19593435
references: BMC Genomics. 2010 Apr 03;11:222
references: 20361874
references: Antimicrob Agents Chemother. 2010 Apr;54(4):1393-403
references: 20065048
references: Curr Biol. 1999 Jul 15;9(14):747-50
references: 10421576
references: Nucleic Acids Res. 2009 Jan;37(Database issue):D396-403
references: 18957448
references: Infect Genet Evol. 2012 Dec;12(8):1911-6
references: 22986003
references: Antimicrob Agents Chemother. 1993 Oct;37(10):2045-53
references: 8257121
references: Bioinformatics. 2003 Nov 22;19(17):2325-7
references: 14630667
references: Methods Mol Biol. 2010;620:105-53
references: 20652502
references: Science. 2008 Jul 18;321(5887):365-7
references: 18635792
references: Bioinformatics. 2009 Feb 15;25(4):451-7
references: 19164304
references: Nucleic Acids Res. 1997 Sep 1;25(17):3389-402
references: 9254694
references: Nature. 2001 Jun 28;411(6841):1046-9
references: 11429604
references: BMC Bioinformatics. 2009 Aug 25;10:263
references: 19703312
references: Vet Res. 2001 May-Aug;32(3-4):261-73
references: 11432417
references: Bioinformatics. 2008 Jul 15;24(14):1650-1
references: 18511468
references: Annu Rev Biochem. 1977;46:573-639
references: 409339
references: PLoS Genet. 2011 Sep;7(9):e1002244
references: 21912525
references: J Antimicrob Chemother. 2001 Jul;48(1):1-6
references: 11418506